Literature DB >> 26450881

IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice.

Mathias Schmaler1, Maria A S Broggi2, Nadège Lagarde2, Benjamin F Stöcklin2, Carolyn G King3, Daniela Finke4, Simona W Rossi1.   

Abstract

Foxp3(+)CD4(+) regulatory T cells (Treg) have a crucial role in controlling CD4(+) T-cell activation, proliferation, and effector function. However, the molecular mechanisms regulating Treg function remain poorly understood. Here we assessed the role of IL-7, a key cytokine regulating T-cell homeostasis, in suppressor capacity of Treg. Using a skin allograft model in which transplant acceptance is controlled by the number of transferred Treg, we find that Treg impair the proliferation of allogeneic CD4(+) T cells, decrease production of IFNγ by effector T cells, and prevent early and increase late IL-7 induction by lymph node stromal cells. Increased IL-7 availability enhanced Treg survival, stabilized Treg molecular signature, enhanced surface IL-2Rα expression, and improved IL-2 binding of Treg, which diminished proliferation of alloreactive CD4(+) T cells. Sequestration of IL-7 or impairment of IL-7R signaling after allograft transplantation abolished Treg-mediated tolerance by limiting their suppressive capacity. Aged Il7rα-ΔTreg mice displayed mild symptoms of autoimmunity correlating with impaired expansion of effector Treg in response to IL-2. Thus, IL-7R signaling on Treg supports the functional activity of effector Treg by increasing their IL-2 sensitivity in the lymph node during peripheral and allograft tolerance.

Entities:  

Keywords:  IL-2; IL-7; IL-7R; regulatory T cell; skin transplantation

Mesh:

Substances:

Year:  2015        PMID: 26450881      PMCID: PMC4629352          DOI: 10.1073/pnas.1510045112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  IL-2, regulatory T cells, and tolerance.

Authors:  Brad H Nelson
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

Review 2.  The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 3.  Harnessing the biology of IL-7 for therapeutic application.

Authors:  Crystal L Mackall; Terry J Fry; Ronald E Gress
Journal:  Nat Rev Immunol       Date:  2011-05       Impact factor: 53.106

4.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

5.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

6.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells.

Authors:  Alexander Link; Tobias K Vogt; Stéphanie Favre; Mirjam R Britschgi; Hans Acha-Orbea; Boris Hinz; Jason G Cyster; Sanjiv A Luther
Journal:  Nat Immunol       Date:  2007-09-23       Impact factor: 25.606

7.  Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations.

Authors:  Shizue Tani-ichi; Akihiro Shimba; Keisuke Wagatsuma; Hitoshi Miyachi; Satsuki Kitano; Kumiko Imai; Takahiro Hara; Koichi Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

8.  IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels.

Authors:  Jana Raynor; Allyson Sholl; David R Plas; Philippe Bouillet; Claire A Chougnet; David A Hildeman
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

9.  Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks.

Authors:  Deepali Malhotra; Anne L Fletcher; Jillian Astarita; Veronika Lukacs-Kornek; Prakriti Tayalia; Santiago F Gonzalez; Kutlu G Elpek; Sook Kyung Chang; Konstantin Knoblich; Martin E Hemler; Michael B Brenner; Michael C Carroll; David J Mooney; Shannon J Turley
Journal:  Nat Immunol       Date:  2012-04-01       Impact factor: 25.606

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  16 in total

1.  Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers.

Authors:  Gabriele Galliverti; Stephan Wullschleger; Mélanie Tichet; Dhaarini Murugan; Nadine Zangger; Wesley Horton; Alan J Korman; Lisa M Coussens; Melody A Swartz; Douglas Hanahan
Journal:  Cancer Immunol Res       Date:  2019-11-26       Impact factor: 11.151

Review 2.  Harnessing bone marrow resident regulatory T cells to improve allogeneic stem cell transplant outcomes.

Authors:  Laetitia Le Texier; Katie E Lineburg; Kelli P A MacDonald
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

Review 3.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

Review 4.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

Review 5.  Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.

Authors:  Kai Yang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

6.  High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Caroline Ritacco; Grégory Ehx; Céline Grégoire; Coline Daulne; Evelyne Willems; Sophie Servais; Yves Beguin; Frédéric Baron
Journal:  Bone Marrow Transplant       Date:  2021-03-04       Impact factor: 5.174

7.  Monoclonal regulatory T cells provide insights into T cell suppression.

Authors:  Céline Gubser; Mathias Schmaler; Simona W Rossi; Ed Palmer
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

Review 8.  Establishment and Maintenance of the Human Naïve CD4+ T-Cell Compartment.

Authors:  Susana L Silva; Ana E Sousa
Journal:  Front Pediatr       Date:  2016-10-31       Impact factor: 3.418

9.  Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7.

Authors:  Susana L Silva; Adriana S Albuquerque; Ana Serra-Caetano; Russell B Foxall; Ana R Pires; Paula Matoso; Susana M Fernandes; João Ferreira; Rémi Cheynier; Rui M M Victorino; Iris Caramalho; João T Barata; Ana E Sousa
Journal:  Oncotarget       Date:  2016-03-15

10.  c-Jun N-terminal kinase 1 defective CD4+CD25+FoxP3+ cells prolong islet allograft survival in diabetic mice.

Authors:  Deepak Tripathi; Satyanarayana S Cheekatla; Padmaja Paidipally; Rajesh Kumar Radhakrishnan; Elwyn Welch; Ramya Sivangala Thandi; Amy R Tvinnereim; Ramakrishna Vankayalapati
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.